Document Detail


The radioisotope stent for the prevention of restenosis.
MedLine Citation:
PMID:  9816524     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The use of intracoronary stenting has revolutionized catheter-based revascularization of obstructive coronary artery disease. These devices provide excellent scaffolding, predictable immediate success with the creation of a large, dissection-free luminal cross-section and improved long-term outcomes, when compared to "plain old balloon angioplasty". Despite these improvements restenosis still occurs at unacceptable rate, particularly in smaller vessels and in longer lesions. In this article we review the concept of using a stent implanted with low activities of radioisotope as a means to inhibit the proliferative process that is believed to initiate in-stent restenosis. The potential advantages, as well as the limitations of this means of intravascular brachytherapy are reviewed. This approach has been shown to be effective in certain animal models of restenosis. The initial clinical results with the Phase I safety trials will be summarized. Future directions for this technology, including the evaluation of new stent designs and new radioisotopes will be discussed. The early clinical results with more than 170 implants of low activity 32P Palmaz-Schatz and BX radioactive stents have demonstrated excellent procedural and 30-day event-free survival. Further dose finding safety trials are anticipated in 1998. Implementation of a large scale randomized clinical trial will commence if and when early safety and efficacy data suggest a therapeutic effect from this technology. Thus, future studies will focus on optimal stent design and will evaluate alternative isotopes and dosing strategies.
Authors:
T A Fischell; C Hehrlein
Related Documents :
9409694 - Predictors of acute and long-term outcome with transluminal extraction atherectomy: the...
14557354 - Sirolimus-eluting stent implantation in st-elevation acute myocardial infarction: a cli...
16263364 - Beta radiation in the treatment of in-stent restenosis of an in situ saphenous vein byp...
16650244 - Intravascular ultrasound in patients with challenging in-stent restenosis: importance o...
9085344 - Advanced cardiac life support controversy: where do antiarrhythmic agents fit in?
19629804 - Pharmacological enhancement of cardiac gap junction coupling prevents arrhythmias in ca...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Herz     Volume:  23     ISSN:  0340-9937     ISO Abbreviation:  Herz     Publication Date:  1998 Sep 
Date Detail:
Created Date:  1999-01-26     Completed Date:  1999-01-26     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  7801231     Medline TA:  Herz     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  373-9     Citation Subset:  IM    
Affiliation:
Heart Institute, Borgess Medical Center, Kalamazoo, MI, USA. taf1@net-link.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary / instrumentation*
Animals
Brachytherapy / instrumentation*
Coronary Disease / radiotherapy*
Equipment Safety
Feasibility Studies
Humans
Prosthesis Design
Rabbits
Recurrence
Stents*
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intracoronary radiation using radioisotope solution-filled balloons.
Next Document:  Intracoronary brachytherapy with strontium/yttrium-90. Initial experiences in Germany